Prothena | PRTA - Market Capitalization

Prothena reported $2.5B in Market Capitalization this March of 2023, considering the latest stock price and the number of outstanding shares.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Market Capitalization Change
Acadia Pharmaceuticals ACAD:US USD 2.58B 70M
Agios Pharmaceuticals AGIO:US USD 1.54B 7M
Akebia Therapeutics AKBA:US USD 106M 48M
ALKERMES ALKS:US USD 4.29B 626M
Alnylam Pharmaceuticals ALNY:US USD 29.24B 4.62B
Amgen AMGN:US USD 140.14B 19.78B
Biogen BIIB:US USD 39.88B 774M
Biomarin Pharmaceutical BMRN:US USD 19.23B 3.51B
Bluebird Bio BLUE:US USD 488M 192M
Exelixis EXEL:US USD 5.17B 128M
Intercept Pharmaceuticals ICPT:US USD 512M 62M
Intra Cellular Therapies ITCI:US USD 5.01B 605M
IONIS PHARMACEUT IONS:US USD 5.36B 913M
Macrogenics MGNX:US USD 413M 200M
Nektar Therapeutics NKTR:US USD 425M 175M
Neurocrine Biosciences NBIX:US USD 11.48B 1.32B
Prothena PRTA:US USD 3.08B 236M
Regeneron Pharmaceuticals REGN:US USD 78.57B 3.48B
Seattle Genetics SGEN:US USD 23.86B 1.38B
Ultragenyx Pharmaceutical RARE:US USD 3.25B 348M
Vertex Pharmaceuticals VRTX:US USD 74.13B 169M
Vital Therapies VTL:US USD 62M 35M
Xoma XOMA:US USD 211M 6M
YTE INCY:US USD 17.87B 3.05B